Glenda E Gray

Author PubWeight™ 99.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa. Lancet 2004 11.28
2 Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection. Soc Sci Med 2004 4.52
3 Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010 4.23
4 New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011 3.46
5 Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009 3.06
6 Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 2010 2.48
7 Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011 2.21
8 Prevalence and patterns of gender-based violence and revictimization among women attending antenatal clinics in Soweto, South Africa. Am J Epidemiol 2004 2.17
9 Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 2009 1.90
10 International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 2011 1.88
11 Knowledge and attitudes towards HIV vaccines among Soweto adolescents. BMC Res Notes 2008 1.72
12 Body mass index and risk of tuberculosis and death. AIDS 2010 1.71
13 Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr 2011 1.67
14 Breast-feeding, antiretroviral prophylaxis, and HIV. N Engl J Med 2008 1.66
15 The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients. J Acquir Immune Defic Syndr 2004 1.60
16 Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr 2006 1.56
17 Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa. J Acquir Immune Defic Syndr 2009 1.49
18 Clinical decisions. Preexposure prophylaxis for HIV prevention. N Engl J Med 2012 1.46
19 African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS 2007 1.46
20 Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS 2010 1.34
21 Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS 2011 1.32
22 Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa. AIDS 2003 1.29
23 Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol 2009 1.25
24 Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol 2006 1.24
25 Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr 2010 1.24
26 Male circumcision for HIV prevention: developments from sub-Saharan Africa. Expert Rev Anti Infect Ther 2010 1.14
27 Uptake of male circumcision in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2009 1.10
28 Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr 2008 1.10
29 Transmission rates in consecutive pregnancies exposed to single-dose nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire. J Acquir Immune Defic Syndr 2007 1.08
30 Morbidity and mortality among infants born to HIV-infected women in South Africa: implications for child health in resource-limited settings. J Trop Pediatr 2010 1.08
31 In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 2006 1.06
32 Circumcision for prevention against HIV: marked seasonal variation in demand and potential public sector readiness in Soweto, South Africa. Implement Sci 2007 1.05
33 A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers. PLoS One 2013 1.04
34 Preferences for characteristics of antiretroviral therapy provision in Johannesburg, South Africa: results of a conjoint analysis. AIDS Behav 2009 1.03
35 Predicting the impact of a partially effective HIV vaccine and subsequent risk behavior change on the heterosexual HIV epidemic in low- and middle-income countries: A South African example. J Acquir Immune Defic Syndr 2007 1.00
36 Identification and characterisation of vaginal lactobacilli from South African women. BMC Infect Dis 2013 1.00
37 Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS 2009 1.00
38 Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: a survey conducted among adolescents in Soweto, South Africa. J Acquir Immune Defic Syndr 2011 0.97
39 Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers. Clin Diagn Lab Immunol 2004 0.97
40 Short-course Combivir after single-dose nevirapine reduces but does not eliminate the emergence of nevirapine resistance in women. Antivir Ther 2011 0.97
41 HIV disclosure and other factors that impact on adherence to antiretroviral therapy: the case of Soweto, South Africa. Afr J AIDS Res 2006 0.96
42 Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection. J Infect Dis 2010 0.95
43 Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention. AIDS Behav 2012 0.95
44 Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics. Trop Med Int Health 2010 0.94
45 Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr 2011 0.93
46 KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa. PLoS One 2011 0.93
47 Development of a whole blood intracellular cytokine staining assay for mapping CD4(+) and CD8(+) T-cell responses across the HIV-1 genome. J Virol Methods 2007 0.92
48 Scientific justification for the participation of children and adolescents in HIV-1 vaccine trials in South Africa. S Afr Med J 2005 0.92
49 Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav 2015 0.91
50 Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS 2009 0.89
51 Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Plan 2010 0.88
52 Influence of culture on contraceptive utilization among HIV-positive women in Brazil, Kenya, and South Africa. AIDS Behav 2011 0.87
53 High rates of HIV in surgical patients in Soweto, South Africa: impact on resource utilisation and recommendations for HIV testing. Trans R Soc Trop Med Hyg 2006 0.87
54 Comparative costs of inpatient care for HIV-infected and uninfected children and adults in Soweto, South Africa. J Acquir Immune Defic Syndr 2007 0.86
55 Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women. PLoS One 2012 0.86
56 KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission. Clin Immunol 2013 0.85
57 Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates. Virus Genes 2003 0.82
58 Correlates of sexual risk among sexual minority and heterosexual South African youths. Am J Public Health 2014 0.82
59 A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents. J Immunol Tech Infect Dis 2013 0.81
60 Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Res Ther 2006 0.81
61 The role of maternal, health system, and psychosocial factors in prevention of mother-to-child transmission failure in the era of programmatic scale up in western Kenya: a case control study. AIDS Patient Care STDS 2015 0.81
62 Low maternal viral loads and reduced granulocyte-macrophage colony-stimulating factor levels characterize exposed, uninfected infants who develop protective human immunodeficiency virus type 1-specific responses. Clin Vaccine Immunol 2007 0.80
63 The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Int J STD AIDS 2013 0.79
64 Progress and Emerging Challenges in Preventing Mother-to-Child Transmission. Curr Infect Dis Rep 2005 0.78
65 Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life. Open AIDS J 2010 0.77
66 Co-trimoxazole prophylaxis in African children with HIV-1. Lancet 2005 0.76
67 Walking the tightrope in prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 2008 0.75
68 Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates. Hum Vaccin Immunother 2012 0.75
69 Maternal antiretroviral prophylaxis and breastfeeding. Antivir Ther 2012 0.75
70 Cautious optimism for HIV vaccine science. Curr Opin HIV AIDS 2013 0.75
71 Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. PLoS Pathog 2017 0.75